1. Introduction {#sec0005}
===============

Gonadal dysgenesis refers to a variety of clinical conditions in which abnormal development of the fetal gonad is present. It consists of 46, XY gonadal dysgenesis, mixed gonadal dysgenesis (MGD), and 45, X Turner syndrome [@bib0005]. MGD, a disorder of sex development (DSD), is defined in individuals who typically have a differentiated gonad on one side and a streak gonad or streak testis (usually intra-abdominal) on the other side. Persistent Müllerian structures such as the ovary or uterus may also be present [@bib0010]. However, true hermaphroditism (TH) cases have both unequivocal ovarian tissue and testicular elements independent to their karyotypes. TH and MGD should be differentiated, and a counseling physician should be consulted to decide for early gonadectomy in MGD to prevent the high risk of malignancy [@bib0015; @bib0020].

Sex chromosome mosaicism (45, XO/46, XY) is the most common karyotype expressed in MGD and may cause formation of a dysgenetic or malformed gonad. This is referred to as a streak gonad that does not produce enough testosterone [@bib0010; @bib0025]. Ambiguous genitalia is the most common presentation for individuals with a 45X/46XY karyotype accounting for about 60% of involved individuals [@bib0030]. In clinical examination, undescended testis (cryptorchidism) and/or hypospadias may be found. For this reason, a chromosomal study via karyotyping is necessary to be done for any patient with penoscrotal hypospadias and undescended testis [@bib0035]. Measurement of the level of anti-Müllerian hormone (AMH), which is usually insufficient in dysgenetic gonad, can also help us to differentiate any type of intersexual condition [@bib0040]. In these conditions, the patients have female reproductive organs such as a hemi-uterus and fallopian tube in testicular dysgenesis [@bib0045]. Meanwhile, patients with impaired testosterone secretion show the level of AMH either within normal limit or slightly elevated [@bib0040].

Y chromosome behavior is a strong risk factor for germ cell tumors [@bib0050]; however, hormone production via saving testis is very varied and depends on each case individually [@bib0055; @bib0060; @bib0065].

The correlation of clinical phenotype in MGD with cancer risk has been shown to be as high as 52% [@bib0060]. In mild MGD, spermatogenesis may be impaired in adulthood, resulting in infertility or subfertility. However in more severe MGD, testicular cancer may be observed at a younger age [@bib0030; @bib0070].

We present a rare case with MGD and a new pattern of chromosome in the karyotype, 45, X/46, X, +mar(Y).

2. Case presentation {#sec0010}
====================

A ten-year-old boy was referred to the pediatrics clinic of Hazrat Rasul Akram Hospital with left-sided cryptorchidism, penoscrotal hypospadias, and growth retardation. His height was 118.7 cm, and his body weight was 22 kg (25th Percentile). He was raised in a nursery center as a result of his father's incompetence and some family problems, which might be the reason why he had not sought any medical advice earlier. His physical examination consisted of a significant short stature, low-set hair line, a gonadal phenotype similar to male genitalia with hypospadias, chordee penis, and a left-sided undescended testis (UDT). In karyotype, 20 metaphases were assessed on the basis of GTG technique at 450--500 band resolution including five plates (25%) of 45X, and the remaining plates (75%) revealed 46 chromosomes with a small marker chromosome (45, X [@bib0025]/46, X, +mar [@bib0075]. Thus, a molecular study was planned to determine the origin of the marker chromosome. In the molecular study, DNA was extracted from peripheral blood leukocytes to seek the sex-determined region of the Y chromosome (SRY) gene by PCR technique. The specific probes for X and Y chromosomes were also applied to approach the origin of the marker in a FISH study. These results revealed presence of both X and Y chromosomes and SRY genes which were compatible with a male phenotype. The laboratory tests are included in [Table 1](#tbl0005){ref-type="table"}.

Ultrasound examination revealed no left testis in the scrotum or inguinal canal, and no sign of remnants of Müllerian structures, such as the uterus, was appreciated. After counseling with the patient, his family, and pediatric psychologist, the decision was made to pronounce the patient male gendered. Subsequently, explorative laparoscopy was offered, and left testis was seen on the left internal ring. In addition, the fallopian tube and a single ovary were seen on the same side, but no uterus was observed. ([Figs. 1 and 2](#fig0005 fig0010){ref-type="fig"}) In the next step, laparoscopy orchiectomy was performed, and remnants of Müllerian duct were excised. In a histopathologic review of specimen, streak ovary, fallopian tube, and testis were confirmed. The patient was referred for urology and endocrinology evaluation, and a trial of GH therapy for treatment of short stature was considered.

3. Discussion {#sec0015}
=============

Sex chromosomal mosaicism is the common karyotype in MGD. Johansen and coworkers reported structural rearrangement of the Y chromosome in 63% of MGD patients [@bib0075; @bib0080]. However, normal XY karyotype was reported by Anand et al. [@bib0085]. In our case, mosaic chromosomal pattern with a chromosome marker was found. Therefore, PCR was performed for the sex-determining region of the Y chromosome (SRY) upon proposal of MGD as the primary diagnosis. Most MGD cases require corrective surgery because of the two mismatched gonads. In case of the decision to convert to male gender, female ductal structures should be removed. If the child's phallus is small, she would function better as a female; therefore, the testis should be removed [@bib0010; @bib0025; @bib0075]. Normal right side testis in our patient produced adequate testosterone to enhance puberty and body shape formation. In addition, the patient was raised as a male, and he preferred to stay as such. Although there is no exact prediction of tumor risk in normal appearing males with mosaic (45X, 46XY) karyotype, tumor risk was anticipated low in our patient due to normal testicular differentiation and maturation process present in the clinical manifestation, including a normal external masculinization score (EMS) and bilaterally descended testes [@bib0090]. Therefore, according to this observation, we decided to preserve our patient's right testis with close follow-up in order to prevent gonadoblastoma formation.

However, early diagnosis and evaluation is very important for preventing psychological sequels as well as ruling out other abnormalities. Meanwhile, a complete and sufficiently careful medical evaluation and genetics counseling of neonates referred to nurseries is highly recommended to avoid any delayed and insufficient diagnostic, conservative, therapeutic, and psychological care in children with guardians rather than their biological parents. These also include exclusion other congenital and/or genetic abnormalities such as congenital adrenal hyperplasia.

Johansen et al. reported an adequate gonadal function in male gender to produce pubertal phase. They showed that EMS, defined by Ahmed et al. [@bib0095], acts as a sign of clinically malfunctioning gonads in patients with a very low EMS [@bib0075]. Phonotypical males with a 45, X/46, XY karyotype and its variants assume to have normal testicular function and spontaneous puberty even in patients with ambiguous genitalia [@bib0090; @bib0100]. However, some patients might need hormone replacement therapy (HRT) after spontaneous pubertal onset [@bib0100]. In male patients with MGD, the cause of infertility is UDT and dysgenetic testis.

The prevalence of growth retardation is high although it seems not to be due to growth hormone (GH) deficiency. In our case, trial of GH therapy for was considered treatment of short stature.

Providing a multidisciplinary approach to managing these children is crucial, like our medical team, which included a pediatric endocrinologist, genetics counselor, laparoscopic surgeon, and psychologist.

4. Conclusion {#sec0020}
=============

Patients with mixed gonadal dysgenesis have a different presentation and variant of chromosomal abnormalities. A multidisciplinary approach is necessary and crucial for early diagnosis and proper management of these patients in order to prevent mental and social sequels.
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The results of the patient's serum tests.

  No   Lab test:            
  ---- -------------------- ------------------
  1    FSH-ECL              1.76 mlU/ml
  2    FSH/LH Ratio         14.67 mIU
  3    LH-ECL               0.12 mIU LOW
  4    Testosterone         \<.025 ng/ml LOW
  5    17OH-Prog            0.25 ng/mlu
  6    DHEA-SO4, ECL        26.7 Micg/dl
  7    Androstendione-RIA   0.4 ng/ml
  8    A.C.T.H              8.5 pg/ml
  9    CORTISOL, ECL (AM)   14.5
  10   WBC                  4500
  11   Hb                   11.5
  12   MCV                  75.3
  13   Blood sugar          79
  14   Sodium               140
  15   Potassium            4.4

*Note*: FSH: follicle-stimulating hormone, ECL: electrochemiluminescency, LH: luteinizing hormone, 17OH-Prog: 17-hydroxy-progesterone, DHEA-SO4: dehydroepiandrosterone, RIA: radioimmunoassay, A.C.T.H: adrenocorticotropic hormone, WBC: white blood cells, Hb: hemoglobin, MCV: mean corpuscular volume.
